Locoregional hyperthermia system EHY-2030

The EHY-2030 device is intended for the adjuvant treatment of glioblastoma in a combination regimen with chemotherapy and/or radiation therapy. The newly designed device includes the Smart Electrode system and the integrated Patient Management System (PMS) and a user-friendly touch screen display with full system control. The new RF generator with impulse mode increased peak power has been developed with a new intelligently controlled step motor tuning system for rapid impedance matching to achieve shorter tuning-time. The EHY-2030 device is a CE-marked medical device, and is intended for professional use. User friendly touch screen display Thanks to the user-friendly touch screen, the parameters and progress of the treatment can be controlled and monitored from start to stop. Innovative design When designing our treatment bed, we also paid special attention to the comfort needs of the patients. Our mattresses combined with a waterbed, as well as the manual Patient Stop Button available to patients can help the patients' pleasant well-being as they could help to overcome the anxiety caused by the treatment. SMArt Electrode system Built-in electrode identification system and electrode ring (with lifetime management) and a counter electrode Continuous communication with the central controller Controlled surface temperature to increase patient comforta The precise placement of the electrodes is supported by an LED indicator Smart Electrode M (max. 150 W) Smart Electrode L (max. 250 W)